Home Newsfeeds Oppenheimer Initiates Coverage On Portman Ridge Finance with Perform Rating, Announces Price Target of $26

Oppenheimer Initiates Coverage On Portman Ridge Finance with Perform Rating, Announces Price Target of $26

Oppenheimer analyst Mitchel Penn initiates coverage on Portman Ridge Finance (NASDAQ:PTMN) with a Perform rating and announces Price Target of $26.

byBenzinga Newsdesk

July 6, 2022

1 minute read

Oppenheimer analyst Mitchel Penn initiates coverage on Portman Ridge Finance (NASDAQ:PTMN) with a Perform rating and announces Price Target of $26.

A Shareholder Lawsuit Stemming From Aphria Could Expose Tilray—Trouble In Cannabis Paradise?

By Joana Scopel

August 31, 7:15 PM

Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY), which closed its acquisition of rival Aphria, Inc. (APHA) in 2021, could face a lawsuit brought by former Aphria shareholders.

TLRY

News
Tech

9 In 10 Teens Own And Will Buy An iPhone Next, Even As Android Boss Hiroshi Lockheimer Laments Losing 10% Users To iPhone Every Year

By Rounak Jain

November 15, 6:33 AM

iPhones are extremely popular amongst teens in the US. Nearly 9 in 10 teens say they either own or will buy an iPhone next.

AAPL

LianBio Announces First Patient Treated In Phase 1 Trial Of SHP2 Inhibitor BBP-398 In Combination With Osimertinib In Patients With Non-Small Cell Lung Cancer With EGFR Mutations

By Benzinga Newsdesk

August 3, 5:23 PM

LianBio (NASDAQ:LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced the first patient has been dosed in its Phase 1 clinical

LIAN

Jefferies Initiates Coverage On Dorian LPG with Buy Rating, Announces Price Target of $20

By Benzinga Newsdesk

July 21, 6:18 AM

Jefferies analyst Omar Nokta initiates coverage on Dorian LPG (NYSE:LPG) with a Buy rating and announces Price Target of $20.

LPG

Oppenheimer Initiates Coverage On Portman Ridge Finance with Perform Rating, Announces Price Target of $26

Related Posts

A Shareholder Lawsuit Stemming From Aphria Could Expose Tilray—Trouble In Cannabis Paradise?

9 In 10 Teens Own And Will Buy An iPhone Next, Even As Android Boss Hiroshi Lockheimer Laments Losing 10% Users To iPhone Every Year

LianBio Announces First Patient Treated In Phase 1 Trial Of SHP2 Inhibitor BBP-398 In Combination With Osimertinib In Patients With Non-Small Cell Lung Cancer With EGFR Mutations

Jefferies Initiates Coverage On Dorian LPG with Buy Rating, Announces Price Target of $20